Transitioning from Academia to Industry

There is a growing need for a collaborative approach to increase the efficiency and impact of drug development in neurological disorders, especially rare and orphan conditions. This has created unique opportunities for neurologists to develop careers that involve both industry and academia. In this podcast, Dr. Andrews, Director of Neuromuscular Clinical Trials at Columbia University, shares her experiences and some of the opportunities and challenges in her career while transitioning between academia and industry. Series 1, episode 6